WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2016095205) HETEROARYL OREXIN RECEPTOR ANTAGONISTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2016/095205    International Application No.:    PCT/CN2014/094370
Publication Date: 23.06.2016 International Filing Date: 19.12.2014
IPC:
C07D 213/26 (2006.01), C07D 239/30 (2006.01), C07D 241/16 (2006.01), A61K 31/4427 (2006.01), A61K 31/501 (2006.01), A61K 31/506 (2006.01), A61P 25/20 (2006.01), A61P 3/04 (2006.01)
Applicants: MERCK SHARP & DOHME CORP. [US/US]; 126 East Lincoln Avenue Rahway, New Jersey 07065 (US).
KUDUK, Scott D. [US/US]; (US) (US only).
LIVERTON, Nigel [GB/US]; (US) (US only).
LUO, Yunfu [CN/CN]; (CN) (US only)
Inventors: KUDUK, Scott D.; (US).
LIVERTON, Nigel; (US).
LUO, Yunfu; (CN)
Agent: WU, FENG & ZHANG CO.; Room 305, Tower B Beijing Aerospace CPMIEC Building No. 30 Haidian South Road Haidian District, Beijing 100080 (CN)
Priority Data:
Title (EN) HETEROARYL OREXIN RECEPTOR ANTAGONISTS
(FR) COMPOSÉS HÉTÉROARYLE EN TANT QU'ANTAGONISTES DU RÉCEPTEUR DE L'HYPOCRÉTINE
Abstract: front page image
(EN)Disclosed are heteroaryl compounds and compositions which are antagonists of orexin receptors. Also disclosed are uses of the compounds and compositions in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved.
(FR)L'invention concerne des composés hétéroaryle et des compositions contenant ces composés, qui sont des antagonistes des récepteurs de l'hypocrétine. La présente invention concerne également des utilisations desdits composés et compositions dans le traitement ou la prévention potentiel(le) de troubles et de maladies neurologiques et psychiatriques dans lesquels sont impliqués les récepteurs de l'hypocrétine.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)